Zacks Research Has Pessimistic Outlook of MHK Q1 Earnings
Equities research analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for Mohawk Industries ...
Zacks Research Analysts Decrease Earnings Estimates for BURL
Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for shares of Burlington ...
Investment research data breach exposes 12 million customers
A recent ransomeware attack targeted Zacks, an American investment firm, and a cybercriminal claimed to have stolen records ...
Top Research Reports for Novo Nordisk, Coca-Cola & Wells Fargo
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), The Coca-Cola ...
Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...
Zacks Investment Research on MSN2d
ACM Research, Inc. (ACMR) Is a Trending Stock: Facts to Know Before Betting on It
ACM Research, Inc. (ACMR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Xeris Biopharma: Q4 Earnings Snapshot
Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $5.1 million in its fourth quarter. The Chicago-based company said it had a loss of 3 cents per share.